The Ontario Institute for Cancer Research

Dr. Janet Dancey

Program Leader, High Impact Clinical Trials

Research Description

Dr. Janet Dancey is the leader of the High Impact Clinical Trials program at OICR and the Director of Clinical Translational Research at the NCIC Clinical Trials Group. The High Impact Clinical Trials program will facilitate the translation of discoveries from laboratory to clinic by providing infrastructure and resources to support trials evaluating markers for early diagnosis, prognosis, and predication of benefit to help develop better treatments for cancer patients.


Contact Information

Telephone (OICR)
416-673-6532

Mailing Address (OICR)
Ontario Institute for Cancer Research
MaRS Centre, South Tower
101 College Street, Suite 800
Toronto, Ontario, Canada M5G 0A3

Telephone (NCIC-CTG)
613-533-6430

Mailing Address (NCIC-CTG)
NCIC Clinical Trials Group
10 Stuart St
Queen’s University
Kingston, Ontario
Canada K7L 3N6

Current

2008 - Program Leader, High Impact Clinical Trials, Ontario Institute for Cancer Research.
2008 - Director, Clinical Translational Research, NCIC Clinical Trials Group.
2008 - Professor, Department of Oncology, Queen's University.


Background        

2007 - 2008 Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute.
1999 - 2007 Senior Clinical Investigator, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute.
1997 - 1999 Assistant Professor, Faculty of Medicine, University of Toronto.
1996 - 1999 Active Staff, Department of Medicine, Division of Hematology/Oncology,
The Toronto Hospital/Ontario Cancer Institute/ Princess Margaret Hospital.
1995 Clinical Research Fellow, Institut Gustave Roussy. Supervisor: Dr Thierry Le Chevalier.
1994 - 1995 Consultant, Kingston Regional Cancer Clinic.
1994 - 1995 Clinical Research Fellow, NCIC Clinical Trials Group. Supervisors: Dr. Joseph L. Pater and Dr. Elizabeth Eisenhauer.
1994, 1996 - 97 Lecturer, Faculty of Medicine, University of Toronto.
1993 - 1994 Medical Oncologist, St. Michael's Hospital, Department of Medicine.
1993            FRCPC Certification in Medical Oncology.
1988 MD, Magna Cum Laude, University of Ottawa.

 

Selected Publications

  1. Dancey J. Early Clinical Trial Design Issues: Patient Populations, Endpoints and Barriers. In: Pandya KJ, Brahmer J, Hidalgo M, editors. Lung Cancer: Translational and Emerging Therapies. New York: Taylor & Francis Group, LLC; 2007.
  2. Dancey J and Chen H. Strategies for optimizing combinations of molecularly targeted anticancer agents.  Nature Reviews Drug Discovery. 5:649-59; 2006.
  3. Dancey JE. Predictive Factors for Epidermal Growth Factor Receptor Inhibitors – The Bull’s-Eye Hits the Arrow. Cancer Cell. 5:411-5; 2004.
  4. Dancey J and Sausville E.  Issues And Progress With Protein Kinase Inhibitors For Cancer Treatment. Nat Rev Drug Discov. 2:296-313; 2003.
  5. Dancey J, Freidlin B. Agents Targeting EGFR: Are We Missing the Mark? Lancet. 362:62-4; 2003.

back   top